Macquarie Group’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,375,000
Closed -$13.8M 1777
2022
Q4
$13.8M Hold
1,375,000
0.02% 768
2022
Q3
$13.5M Hold
1,375,000
0.02% 763
2022
Q2
$13.4M Hold
1,375,000
0.02% 797
2022
Q1
$13.4K Hold
1,375,000
0.01% 866
2021
Q4
$13.3M Hold
1,375,000
0.01% 868
2021
Q3
$13.3M Buy
+1,375,000
New +$13.3M 0.01% 861

Other funds holding AONC

Macquarie Group's AONC Position: Q1 2023 in Review

Macquarie Group sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 1,375,000 shares — an estimated $13.8M sold.

Macquarie Group first reported a position in AONC in Q3 2021 and held it in 6 quarters. The position peaked at $13.8M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Macquarie Group reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Macquarie Group sold 1,375,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $13.8M.
  • Macquarie Group first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
  • Macquarie Group's American Oncology Network, Inc. Class A Common Stock position peaked at $13.8M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Macquarie Group's 13F filing for Q1 2023, filed 15 May 2023.